EMA: What do I need if I want to run an overdose study [Regulatives / Guidelines]

posted by jag009  – NJ, 2020-01-28 20:12  – Posting: # 21092
Views: 1,823

Hi all,

Need some help with running studies in Europe. If I want to run a PK study under each of the two scenarios:
  1. With a drug that is not approved in Europe but approved in USA, and i want to dose at a total daily dose higher than the total daily dose per label in USA.
  2. With a drug that is approved in Europe but at a higher total daily dose than that on the label.
What do I need to file? I know in US I need IND, in Canada I need a full CTA (30 days). what about in Europe? how long?


Complete thread:

 Admin contact
20,465 posts in 4,298 threads, 1,414 registered users;
online 4 (1 registered, 3 guests [including 3 identified bots]).
Forum time (Europe/Vienna): 17:44 CEST

Confidence is the result of hours and days and weeks and years
of constant work and dedication.    Roger Staubach

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz